Neogen Chemicals: Board approves Rs 600 cr fund raising plan, Q1 profit up
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 1.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Neogen Chemicals board approved raising up to Rs 600 crores via equity shares, QIP or other eligible instruments in one or more tranches. Q1 FY27 standalone profit rose to Rs 19.44 cr from Rs 14.23 cr YoY, revenue at Rs 252.28 cr. Crisil downgraded ratings to A-/Negative (long-term) and A2 (short-term); NCD coupon hiked to 11% from 10.50%. Record date Aug 13 for FY26 dividend. AGM on Aug 21.
Possible equity dilution ahead. Rating downgrade is negative. Q1 profit growth and dividend record date are positives for shareholders.